Gonadotropin-releasing hormone agonist cotreatment during chemotherapy may increase pregnancy rate in survivors

Oncologist

Volumn 20, Issue 11, 2015, Pages 1283-1289

  Blumenfeld, Zeev ^a   Zur, Hllli ^a   Dann, Eldad J ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Fertility preservation; Gonadotropin releasing hormone agonist; Pregnancies after gonadotoxic chemotherapy; Premature ovarian failure

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GONADORELIN; GONADORELIN AGONIST; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; HODGKIN DISEASE; HUMAN; LEUKEMIA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY FUNCTION; PREGNANCY RATE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AGONISTS; ANALOGS AND DERIVATIVES; COMPLICATION; DRUG EFFECTS; FERTILITY; GENITAL NEOPLASMS, FEMALE; GROWTH, DEVELOPMENT AND AGING; MULTIMODALITY CANCER THERAPY; OVARY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRIMARY OVARIAN INSUFFICIENCY; SURVIVOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FERTILITY; FERTILITY PRESERVATION; GENITAL NEOPLASMS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY RATE; PRIMARY OVARIAN INSUFFICIENCY; SURVIVORS;

EID: 84946600667     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2015-0223     Document Type: Article

References (28)

1. Blumenfeld Z, Katz G, Evron A. ‘An ounce of prevention is worth a pound of cure’: The case for and against GnRH-agonist for fertility preservation. Ann Oncol 2014;25:1719-1728.
2. De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet 2014; 384:1302-1310.
3. Blumenfeld Z. Howtopreservefertilityinyoung women exposed to chemotherapy?: The role of GnRH agonist in addition to cryopreservation of embryos, oocytes, or ovaries. The Oncologist 2007; 12:1044-1054.
4. Blumenfeld Z, von Wolff M. GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 2008;14:543-552.
5. Loren AW, Mangu PB, Beck LN et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500-2510.
6. Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonad-ectomy: A committee opinion. Fertil Steril 2013;100: 1214-1223.
7. Peccatori FA, Azim HA Jr., Orecchia R et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi160-vi170.
8. Blumenfeld Z, Patel B, Leiba R et al. Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation. Fertil Steril 2012;98:1266-1270.e1.
9. Blumenfeld Z, Avivi I, Eckman A et al. Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 2008;89:166-173.
10. Turner NH, Partridge A, Sanna G. Utility of gonadotropin-releasing hormone agonists for fer- tility preservation in young breast cancer patients: The benefit remains uncertain. Ann Oncol 2013;24: 2224-2235.
11. Del Mastro L, Ceppi M, Poggio F et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treat Rev 2014;40:675-683.
12. Behringer K, Thielen I, Mueller H et al. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin StudyGroup HD14 trial. Ann Oncol 2012;23:1818-1825.
13. Chen H, Li J, Cui T et al. Adjuvantgonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2011;CD008018.
14. Moore HC, Unger JM, Phillips KA et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med 2015;372:923-932.
15. Lambertini M, Boni L, Michelotti A et al. Long-term outcome results of the phase III PROMISE-GIM6 study evaluating the role of LHRH analog during chemotherapy as a strategy to reduce ovarian failure in early breast cancer patients. Paper presented at: ASCO Breast Cancer Symposium, San Francisco, California; September 4, 2014. Abstract 105.
16. Demeestere I, Brice P, Peccatori FA et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial. J Clin Oncol 2013;31: 903-909.
17. Fleisher LA, Bass EB, McKeown P. Methodological approach: American College of Chest physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005;128:17S-23S.
18. Nitzschke M, Raddatz J, Bohlmann MK et al. GnRH analogs do not protect ovaries from chemotherapy-induced ultrastructural injury in Hodgkin’s lymphoma patients. Arch Gynecol Obstet 2010;282:83-88.
19. Remérand G, Merlin E, Froissart R et al. Four successful pregnancies in a patient with mucopolysaccharidosis type I treated by allogeneic bone marrow transplantation. J Inherit Metab Dis 2009; 32(Suppl 1):S111-S113.
20. Blumenfeld Z, Zuckerman T. Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatment. The Oncologist 2010;15: 59-60.
21. Salooja N, Szydlo RM, Socie G et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: A retrospective survey. Lancet 2001;358:271-276.
22. Carter A, Robison LL, Francisco L et al. Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: Report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant 2006;37:1023-1029.
23. Sklar CA, Mertens AC, Mitby P et al. Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. J Natl Cancer Inst 2006;98:890-896.
24. Green DM, Sklar CA, Boice JD Jr. et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J Clin Oncol 2009;27: 2374-2381.
25. Edgar AB, Wallace WH. Pregnancy in women who had cancer in childhood. Eur J Cancer 2007;43: 1890-1894.
26. Wong M, O’Neill S, Walsh G et al. Goserelin with chemotherapy to preserve ovarian function in pre-menopausal women with early breast cancer: Menstruation and pregnancyoutcomes. Ann Oncol 2013;24:133-138.
27. Francis PA, Regan MM, Fleming GF et al. Adjuvant ovarian suppression in premenopausal breast cancer. N Engl J Med 2015;372:436-446.
28. Coates AS, Winer EP, Goldhirsch A et al. Tailoring therapies-improving the management of early breast cancer: St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 2015;26:1533-1546.